Literature DB >> 6651705

Evaluation and use of a micro-broth dilution procedure for testing sensitivity of fermentative avian mycoplasmas to antibiotics.

K G Whithear, D D Bowtell, E Ghiocas, K L Hughes.   

Abstract

A micro-broth dilution procedure is described for testing the sensitivity of glucose-fermenting avian mycoplasmas to antibiotics. A systematic evaluation was made of potential sources of variation that could affect the reliability of this procedure. Strain WVU 1853 of Mycoplasma synoviae (MS) was used as a standard culture and was tested against the antibiotics erythromycin, spiramycin, streptomycin, tetracycline, tiamulin, and tylosin. Inoculum density, duration of incubation before the test was read, and initial pH of the medium significantly affected test results. Type of serum and concentration of pig serum in the medium had little effect, provided the test was read when the phenol red indicator in the medium of a culture control (without antibiotic) had changed from deep red (pH 7.8) to orange-yellow (pH 7). The presence of bacterial inhibitors in the medium, the solvents used to dissolve some antibiotics, the use of thawed or actively growing cultures, and the number of passages of the culture before testing did not appear to be significant causes of test variation. By controlling important sources of variation, a standardized test was developed that gave reproducible results. The standardized test was used to determine the sensitivity to antibiotics of 49 strains of M. gallisepticum (MG), eight strains of MS, five strains of M. pullorum, seven strains of M. gallinaceum, and one strain of M. columborale. Minimum inhibitory concentrations of the macrolide antibiotics were lower for the majority of MG strains than for the other Mycoplasma species tested. However, some strains of MG showed acquired resistance to the macrolide antibiotics. These strains also showed increased resistance to lincomycin and tiamulin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6651705

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  13 in total

1.  In vitro and in vivo efficacies of T-3811ME (BMS-284756) against Mycoplasma pneumoniae.

Authors:  M Takahata; M Shimakura; R Hori; K Kizawa; Y Todo; S Minami; Y Watanabe; H Narita
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

2.  In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone.

Authors:  M Takahata; J Mitsuyama; Y Yamashiro; M Yonezawa; H Araki; Y Todo; S Minami; Y Watanabe; H Narita
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

3.  Expression of two members of the pMGA gene family of Mycoplasma gallisepticum oscillates and is influenced by pMGA-specific antibodies.

Authors:  P F Markham; M D Glew; G F Browning; K G Whithear; I D Walker
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Homologue of macrophage-activating lipoprotein in Mycoplasma gallisepticum is not essential for growth and pathogenicity in tracheal organ cultures.

Authors:  Philip F Markham; Anna Kanci; György Czifra; Bo Sundquist; Peter Hains; Glenn F Browning
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

5.  Agar disk diffusion and automated microbroth dilution produce similar antimicrobial susceptibility testing results for Salmonella serotypes Newport, Typhimurium, and 4,5,12:i-, but differ in economic cost.

Authors:  Karin Hoelzer; Kevin J Cummings; Lorin D Warnick; Ynte H Schukken; Julie D Siler; Yrjo T Gröhn; Margaret A Davis; Tom E Besser; Martin Wiedmann
Journal:  Foodborne Pathog Dis       Date:  2011-08-30       Impact factor: 3.171

6.  In vitro antibiotic susceptibility testing of clinical isolates of Mycoplasma penetrans from patients with AIDS.

Authors:  M M Hayes; H H Foo; J Timenetsky; S C Lo
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

7.  Molecular cloning of a member of the gene family that encodes pMGA, a hemagglutinin of Mycoplasma gallisepticum.

Authors:  P F Markham; M D Glew; K G Whithear; I D Walker
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

8.  Autoimmune-Disease-Prone NOD Mice Help To Reveal a New Genetic Locus for Reducing Pulmonary Disease Caused by Mycoplasma pulmonis.

Authors:  Glenn F Browning; Thomas C Brodnicki; Nadeeka K Wawegama; Philip F Markham; Colleen M Elso; Anna Kanci; Marc S Marenda
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

9.  In vitro antibiotic susceptibility testing of different strains of Mycoplasma fermentans isolated from a variety of sources.

Authors:  M M Hayes; H H Foo; H Kotani; D J Wear; S C Lo
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

10.  The PK/PD Interactions of Doxycycline against Mycoplasma gallisepticum.

Authors:  Nan Zhang; Xiaoyan Gu; Xiaomei Ye; Xun Wu; Bingxu Zhang; Longfei Zhang; Xiangguang Shen; Hongxia Jiang; Huanzhong Ding
Journal:  Front Microbiol       Date:  2016-05-04       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.